Stockreport

Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates

Genelux Corporation  (GNLX) 
PDF - Inclusion into the broad-market Russell 3000® Index and small-cap Russell 2000® Index - - Publication of VIRO-15 Phase 2 data in JAMA Oncology - - $51 Million ra [Read more]